奈帕芬胺
此條目可参照英語維基百科相應條目来扩充。 (2024年8月11日) |
臨床資料 | |
---|---|
商品名 | Nevanac, Ilevro, Amnac, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a606007 |
核准狀況 | |
懷孕分級 | |
给药途径 | Topical eye drops |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
识别信息 | |
| |
CAS号 | 78281-72-8 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.207.414 |
化学信息 | |
化学式 | C15H14N2O2 |
摩尔质量 | 254.29 g·mol−1 |
3D模型(JSmol) | |
| |
|
奈帕芬胺(英語:Nepafenac,商品名:Nevanac、Ilevro等)是一种含氮有机化合物,分子式C15H14N2O2,属于非甾体抗炎药(NSAID),可作为眼藥水處方藥[3],其在体内的活性代謝產物为氨芬酸[4][5]。
参考文献
- ^ Nepafenac ophthalmic Use During Pregnancy. Drugs.com. 6 June 2019 [13 September 2020].
- ^ Prescription medicines: registration of new chemical entities in Australia, 2015. Therapeutic Goods Administration (TGA). 21 June 2022 [10 April 2023].
- ^ Nepafenac Monograph
- ^ Drugbank: Nepafenac
- ^ Zanetti FR, Fulco EA, Chaves FR, da Costa Pinto AP, Arieta CE, Lira RP. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology. July 2012, 60 (4): 277–81. PMC 3442462 . PMID 22824596. doi:10.4103/0301-4738.98705 .
外部链接
- Nepafenac. Drug Information Portal. U.S. National Library of Medicine.